You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 24, 2025

Claims for Patent: 10,945,985

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,945,985

Title:	Fumarate ester dosage forms
Abstract:	Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.
Inventor(s):	Jason M. Vaughn, Justin R. Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
Assignee:	Banner Life Sciences LLC
Application Number:	US16/129,887
Patent Claims:	1. An oral pharmaceutical composition comprising an immediate releasing single phase non-aqueous liquid vehicle comprising a suspension of a fumarate ester or a salt thereof having the formula: 2. The composition of claim 1, wherein the composition comprises about 80 mg to about 230 mg of the fumarate ester or salt thereof. 3. The composition of claim 1, wherein the composition comprises about 80 mg to about 115 mg or about 160 mg to about 230 mg of the fumarate ester or salt thereof. 4. The composition of claim 1, wherein the liquid vehicle comprises mono- and di-glycerides, polyvinylpyrrolidone, and polyoxyl 40 hydrogenated castor oil. 5. The composition of claim 1, wherein the composition comprises: about 30% to about 40% by weight of the composition of the fumarate ester or salt thereof; and about 55% to about 65% by weight of the composition of the liquid vehicle. 6. The composition of claim 1, wherein the liquid vehicle comprises about 5% by weight of the composition of lactic acid. 7. The composition of claim 1, wherein the composition is encapsulated in a capsule. 8. The composition of claim 7, wherein the capsule provides delayed release of the fumarate ester or salt thereof. 9. The composition of claim 1, wherein upon administration to a subject, the composition activates a nuclear factor erythroid-derived 2-like (Nrf2) dependent pathway. 10. An oral pharmaceutical composition comprising an immediate releasing single phase non-aqueous liquid vehicle comprising: mono- and di-glycerides, polyvinylpyrrolidone, and polyoxyl 40 hydrogenated castor oil, and lactic acid; and a suspension of about 95 mg of a fumarate ester or a salt thereof having the formula: 11. The composition of claim 10, wherein the composition comprises: about 30% to about 40% by weight of the composition of the fumarate ester or salt thereof; about 55% to about 65% by weight of the composition of the liquid vehicle comprising mono- and di-glycerides, polyvinylpyrrolidone, and polyoxyl 40 hydrogenated castor oil; and and about 5% by weight of the composition of lactic acid. 12. The composition of claim 10, wherein the composition is encapsulated in an enterically coated soft capsule. 13. The composition of claim 11, wherein the enterically coated soft capsule provides delayed release of the fumarate ester or salt thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.